Introduction
The essential roles of Bax and Bak in apoptosis were demonstrated by the complete resistance of BaxBak double knockout (DKO) mouse embryonic fibroblast (MEF) cells to a variety of apoptotic stimuli (Wei et al., 2001) and the finding that pro-apoptotic BH3-only proteins such as Bim and Puma act through Bax/Bak . Bax and Bak appear functionally redundant, as loss of Bax or Bak alone does not provide significant protection against apoptosis (Lindsten et al., 2000 , Wei et al., 2001 . However, growing evidence suggests that Bax and Bak have non-redundant roles in apoptosis induced by certain specific stimuli, at least in human cells. For example, Bak or Bax single knockdown renders HeLa cells resistant to Ngo or cisplatininduced apoptosis (Kepp et al., 2007) . Bax-deficient or Bak-knockdown human glioblastoma multiforme tumor cells are also refractory to UV, staurosporine (STS) and doxorubicin (Cartron et al., 2003) . The BH3-only protein natural born killer (NBK)/Bcl-2-interacting killer (Bik) has been shown to act entirely through Bax in human cells (Gillissen et al., 2003) , but is solely dependent on Bak in mouse cells (Shimazu et al., 2007) .
Unlike Bax-deficient MEF cells, Bax À/À HCT116 cells are extremely resistant to non-steroidal anti-inflammatory drugs (NSAIDs) (Zhang et al., 2000) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (Deng et al., 2002; von Haefen et al., 2004) . As Bak is expressed at similar levels in Bax À/À as in the wild type (WT) HCT116 cells and is functional (Theodorakis et al., 2002) , it suggests that Bax is predominantly required for a large variety of apoptotic stimuli in certain cell lineages. Another possibility is that Bak is completely suppressed by some inhibitors such as Bcl-xL and Mcl-1 . Although Bak activation is absent in Bax À/À HCT116 cells upon cisplatin exposure (Kepp et al., 2007) or NBK overexpression (Gillissen et al., 2007) , it has never been tested whether or not Bak activation occurs in WT HCT116 cells in response to those particular stimuli. Hence, it is not clear whether Bax is required for Bak activation (directly or indirectly) or certain apoptotic stimuli only specifically activate Bax but not Bak. 
Results

Generation of Bak
À/À and Bax À/À Bak À/À DKO cells Bax seems to be the key pro-apoptotic factor in human cells as Bax À/À HCT116 cells are extremely resistant to apoptosis (Zhang et al., 2000) and Bak appears to be dispensable for apoptosis based on gene-knockdown studies (Cartron et al., 2003; Chandra et al., 2005; Gillissen et al., 2007 Gillissen et al., , 2010 . In order to explicitly dissect the role of Bak in apoptosis, we sought to knock out Bak by homologous recombination in HCT116 cells. We targeted exon 5 of the Bak gene. Exon 5 encodes the BH1 domain and a part of the BH2 domain, whereas the BH3 domain is located on exon 4 and the transmembrane domain resides on exon 6 (Figure 1a) . Targeting exon 5 would result in a C-terminal-truncated protein lacking the transmembrane domain (due to the premature stop codon introduced by the targeting vector, Figure 1d ) or an N-terminal truncated protein lacking the BH3 domain. As the transmembrane domain is essential for mitochondrial localization of Bak and the BH3 domain is central to its apoptotic activity, either of these truncated proteins would be inactive. A promoterless gene-targeting vector was employed (Topaloglu et al., 2005) . In combination with the effective rAAV transduction system (Kohli et al., 2004) The experiment was repeated three times and a representative image was shown. The P-value was obtained using the Student's t-test. *Po0.05; **Po0.01; ***Po0.001.
whereas Bak À/À cells exhibit similar sensitivity as the WT cells ( Figure 2e ).
Finally, we conducted clonogenic assays. Again, although no colony survival was detected in the WT and Bak À/À cells upon sulindac-acid or ABT-737 treatment, similar numbers of colonies were observed in Bax À/À and Bax Figure 2f ). Altogether, these data strongly suggest that Bax, not Bak, has a major role in apoptosis in HCT116 cells and Bak seems to be dispensable. However, Bax À/À cells are significantly less resistant to camptothecin treatment (either 24 or 48 h) than Bax (Figure 2c ), indicating that Bak does have a role in apoptosis against certain stimuli. In support of this, no colony survival can be detected in either Bax À/À or Bak À/À cells after 4 days of STS treatment, whereas a substantial number of colonies survived with Bax Figure 2f ). Therefore, Bak can be activated to mediate apoptosis under certain circumstances or extended treatment, but remains inactive when Bax is not present under most conditions.
Bak is involved in 5-FU-induced apoptosis even when Bax is present
Bax À/À HCT116 cells display moderate resistance to 5-FU, as reported previously (Zhang et al., 2000) , suggesting that Bak might be involved in 5-FU-induced apoptosis. Indeed, Bak Figure 3c ). Bak is also shown to be required for cisplatin-induced apoptosis (Kepp et al., 2007) using Bak siRNA. In contrast, we found that loss of Bax but not Bak provides strong protection whereas the loss of both Bax and Bak leads to complete resistance to cisplatin (Figure 3a ). This indicates that Bak is dispensable for cisplatin-induced cell death when Bax is present, but becomes essential for apoptosis when Bax is absent.
Bak is responsive to puma activation in the absence of Bax Is Bax/Bak differentially activated by various apoptotic stimuli as suggested by previous reports (Deng et al., 2002; Cartron et al., 2003; As Bak is mainly sequestered by Bcl-xL and Mcl-1 whereas Bax could be bound by Bcl-2, Bcl-w, Bcl-xL and Mcl-1 (Willis et al., , 2007 , it is not surprising that NBK, which specifically binds Bcl-xL and Mcl-1, is completely dependent on Bak for killing activity in murine immortalized baby mouse kidney (iBMK) cells (Shimazu et al., 2007) . However, NBK is reported to be solely dependent on Bax in HCT116 cells (Gillissen et al., 2007) . To address this discrepancy, we tested NBK's killing in our Bak À/À and Bax 
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C Wang and RJ Youle HCT116 cells (Gillissen et al., 2007) . The fact that both ABT-737 and Noxa sensitize Bax À/À cells to NBK (Figures 4b and c) suggests that NBK might be able to sequester Mcl-1 in human cells, but not as efficiently as in murine cells. Bcl-xS has also been shown to be exclusively dependent on Bak in MEFs as it kills both WT and Bax À/À MEFs very effectively (Lindenboim et al., 2005) . However, untagged Bcl-xS does not even kill WT HCT116 cells (Figure 4c ) although it does sensitize Bax À/À HCT116 cells to ABT-737 treatment, acting like Noxa (Figure 4c ).
Bak activation is dependent on Bax indirectly
It has been reported that Mcl-1 has low binding affinity to Bax and overexpression of Mcl-1 does not block overexpression of Bax-induced cell death (Zhai et al., 2008) . This is consistent with the observation here that (Figure 5c ). In contrast to a previous report (Zhai et al., 2008) , overexpression of either Bcl-xL or Mcl-1 blocks the killing ability of Bax overexpression (Figure 5c ). This is consistent with previous observations that overexpression of Bcl-xL or Mcl-1 can still protect Bak m2 mutant from apoptosis (Kim et al., 2006) .
Given that Bax À/À HCT116 cells are resistant to a variety of apoptotic agents, it is not unexpected that Bak activation is not observed in Bax À/À cells. But is Bax required for Bak activation? To test this, we performed immunoprecipitation with antibodies that can detect activated Bak (ab-1). Although activated Bak is readily detected in WT cells with either camptothecin or ABT-737 treatment, there is no Bak activation in the Bax À/À cells under these conditions (Figure 5d ). This is further confirmed by confocal imaging of Bak À/À cells and Bax Figure 1 ). Corroborating this, immunoprecipitation with anti-Bak ab-1 antibody in GFP-Bak stably expressing cells also clearly showed that Bak activation occurs normally in response to ABT-737 or camptothecin treatment, but is largely reduced when Bax is absent (Figure 5f ). These data suggest that Bak can be activated during many death stimuli-induced apoptosis when Bak seems to be dispensable, which is likely indirectly dependent on Bax. It has also been shown that Bak can be activated by actinomycin D and STS in MCF-7 cells (Neise et al., 2008) . Three common Bak antagonists, Bcl-xL, Mcl-1 and VDAC2, are expressed at similar levels in the WT, Bax 
Discrepancy of Bax/Bak-mediated apoptosis in HCT116 and MEF cells
The discrepancies on Bax versus Bak-dependent apoptotic responses reported in published studies could be due to different experimental settings, apoptotic treatments and cell lines (see Table 1 ). In order to gain insight into this discrepancy, we sought to compare Bax/Bak-mediated apoptosis in HCT16 and MEF cells directly under the same experimental settings. First, as previously reported (Wei et al., 2001) , Bak À/À MEF and Bax À/À MEF cells are similarly sensitive to STS as WT MEF cells, whereas Bax (Figure 7b) . Second, as previously reported (van Delft et al., 2006) , even WT MEFs seem to be resistant to ABT-737, as 20 mM ABT-737 induces very limited apoptosis indicated by both caspase-3/7 activity (Figure 7c ) and Cyt.c release (Figure 7d ). Bak À/À MEF and Bax À/À MEF seem to be as sensitive to ABT-737 as WT MEF cells (Figures 7c  and d) . Third, unlike untagged Bcl-xS (Figure 4d ), GFP-tagged Bcl-xS does induce cell death in HCT116 cells (Figure 7e ), although it is much less potent than in MEF cells (Figure 7f ). Even in MEF cells, GFP-Bcl-xS triggers moderate cell death comparing with Bim, NBK or Puma (Figure 7f) . Nonetheless, in both species, Bcl-xS seems to preferentially trigger Bak-mediated cell death, consistent with a previous report (Lindenboim et al., 2005) . Fourth, in both species, Puma-induced apoptosis is completely dependent on Bax and Bak (Figures 7e and f) . Moreover, although NBK-induced apoptosis seems to be dependent on Bax (Figures 4c  and d ) in human cells, Bax and Bak are equally involved in NBK-induced cell death in murine cells (Figure 7f ). In addition, Bim is able to induce Bax/Bak-independent apoptosis in both HCT116 and MEF cells (Figures 7e  and f) . However, it does require much higher expression level of Bim to kill BaxBak DKO cells than the WT cells (data not shown).
Discussion
Although some members of the intrinsic cell death pathway are conserved between nematodes and mammals, the two essential core pro-apoptotic proteins, Bax and Bak, are missing from the C. elegans genome. Bcl-2-like proteins in Drosophila are more closely related to Bok. Nonetheless, Bax and Bak orthologs have been recently found in many ancient species such as Hydra (Dunn et al., 2006) and sea anenome (Zmasek et al., 2007) . Bax and Bak appear to have been lost several times during evolution as the zebrafish genome contains only Bax orthologs but not Bak (Kratz et al., 2006) , and sea urchin retains Bak but not Bax orthologs (Dunn et al., 2006) . However, zBax2, although more closely related to human Bax than hBak, behaves functionally like hBak as it cannot be antagonized by the Bcl-2 ortholog in zebrafish (Kratz et al., 2006 whether the evolution of Bax and Bak in mammals reflects the regulatory complexity of these species or acts as a surveillance mechanism so that proper cell death proceeds in case the other has been shut off. Bax and Bak have been long believed to be redundant to one another as Bax À/À and Bak À/À MEFs or BMK cells are both sensitive to various apoptotic stimuli such as STS, etoposide, UV-C and serum withdraw (Lindsten et al., 2000; Wei et al., 2001; Degenhardt et al., 2002) . However, they can be counteracted by distinct antiapoptotic Bcl-2 family proteins. Bak is specifically bound by Bcl-xL and Mcl-1, whereas Bax can be inhibited by Bcl-2, Bcl-w, Bcl-xL and Mcl-1 (Willis et al., , 2007 . Therefore, Bak seems to be less restrained than Bax. Consistently, loss of Bak, in general, provides better protection against apoptosis than the loss of Bax, when certain stimuli only remove the inhibitory effects of a subset of Bcl-2 family proteins (Table 1) . For instance, Bak À/À MEF cells are reported to be more resistant to UV-C treatment than Bax À/À MEFs . Bax À/À MEFs are more sensitive than Bak À/À MEFs to the killing of a Noxa m3 mutant, which can inhibit Bcl-xL, Bcl-w and Mcl-1 (Willis et al., 2007) . Corroborating this, both Bak 
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À/À iBMK cells to NBK, which only binds Bcl-xL and Mcl-1 (Shimazu et al., 2007) .
However, this does not appear to be the case in human colon cancer cells. First, it has been shown that Bax À/À HCT116 cells are resistant to many apoptotic insults such as indomethacin, sulindac acid, 5-FU, TRAIL and ABT-737 (Zhang et al., 2000; Deng et al., 2002; Gillissen et al., 2010 (Konopleva et al., 2006) or HEK293 cells (Zhai et al., 2008) . In addition, when endogenous Mcl-1 is inhibited by stably expressing Noxa or siRNA silencing, Bax À/À HCT116 cells became as sensitive to ABT-737, camptothecin, or TRAIL as WT cells (Figure 4b and Figure 6 ) (Gillissen et al., 2010) , indicating that Bak, on the other hand, is still kept in check by Mcl-1 in the absence of Bax in HCT116 cells. Although VDAC2 was reported to be the main antagonist to keep Bak in check (Kim et al., 2006) , our data show that it is Mcl-1 that keeps Bak in check in Bax À/À HCT116 cells. However, in WT cells, once Bax is activated and oligomerized, the Mcl-1 inhibitory effect on Bak is removed indirectly. Second, NBK exclusively (Gillissen et al., 2007) . It has also been shown that NBK/Bik does not bind Mcl-1 in HCT116 cells (Gillissen et al., 2007) . However, we found that like Noxa, NBK also sensitizes Bax In summary, our data strongly suggest that Bax and Bak are functional redundant although they appeared to have non-redundant roles due to the extreme resistance of Bax KO HCT116 cells to apoptosis (LeBlanc et al., 2002; Cartron et al., 2003; Gillissen et al., 2003 Gillissen et al., , 2007 Kepp et al., 2007) . Once the inhibitory effect of Mcl-1 on Bak is removed by Noxa overexpression (Figure 4b ) (Konopleva et al., 2006) , Mcl-1 knockdown ( Figure 6 ) (Gillissen et al., 2010) or increased Bak expression (Figure 5c ) (LeBlanc et al., 2002) , Bax À/À HCT116 cells become as sensitive as WT cells. In addition, significant differences on the interaction specificity between anti-and pro-apoptotic proteins might exist between human and mice (such as the effect of NBK). As HCT116 cells are less refractory to lipid-based transfection than MEF cells, the Bak À/À and Bax À/À Bak À/À DKO HCT116 cells provide a complete set complementary to the widely used Bax À/À HCT116 cells and shall be a valuable tool for more relevant studies on chemotherapeutic drugs and cancer. Cyt.c release in HCT116 (e) or MEF (f) cells transfected with GFP-tagged BH-3 only proteins and GFP-Bcl-xS for 24 h. GFP-C1 vector was used as a control. The experiment was repeated twice and representative data were shown as average ± s.d. The P-value was obtained using the Student's t-test. *Po0.05; **Po0.01; ***Po0.001.
